Ascendis Pharma A (ASND) Shares Outstanding (Diluted) (2012 - 2026)
Ascendis Pharma A's Shares Outstanding (Diluted) came in at 33.63 million for the quarter ended Jun 30, 2026, unchanged from 33.63 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Ascendis Pharma A (ASND) Shares Outstanding (Diluted) (2012 - 2026) Analysis & Trends
Going back to the quarter ended Dec 31, 2012, Ascendis Pharma A's Shares Outstanding (Diluted) data covers 52 quarters.
- Shares Outstanding (Diluted) carries a five-year compound annual growth rate of 0.0% (years ended Dec 2020 to Dec 2025).
- Going back by year, Shares Outstanding (Diluted) was 33.63 million in the year ended Dec 31, 2024 (unchanged), 33.63 million in the year ended Dec 31, 2023 (unchanged), 33.63 million in the year ended Dec 31, 2022 (unchanged) and 33.63 million in the year ended Dec 31, 2021 (unchanged).
- Business Quant data shows ASND's Shares Outstanding (Diluted) at 33.63 million (quarter ended Mar 31, 2026), 33.63 million (quarter ended Dec 31, 2025) and 33.63 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Ascendis Pharma A | 14.12 Bn | 10.37 Bn | 362.22 Mn | 33.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.63 Mn |
| Mar 31, 2026 | 33.63 Mn |
| Dec 31, 2025 | 33.63 Mn |
| Sep 30, 2025 | 33.63 Mn |
| Jun 30, 2025 | 33.63 Mn |
| Mar 31, 2025 | 33.63 Mn |
| Dec 31, 2024 | 33.63 Mn |
| Sep 30, 2024 | 33.63 Mn |
| Jun 30, 2024 | 33.63 Mn |
| Mar 31, 2024 | 33.63 Mn |
| Dec 31, 2023 | 33.63 Mn |
| Sep 30, 2023 | 33.63 Mn |
| Jun 30, 2023 | 33.63 Mn |
| Mar 31, 2023 | 33.63 Mn |
| Dec 31, 2022 | 33.63 Mn |
| Sep 30, 2022 | 33.63 Mn |
| Jun 30, 2022 | 33.63 Mn |
| Mar 31, 2022 | 33.63 Mn |
| Dec 31, 2021 | 33.63 Mn |
| Sep 30, 2021 | 33.63 Mn |
API Access
Ascendis Pharma A Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();